Odonate Therapeutics, Inc. Common Stock
ODT was delisted on the 14th of January, 2022.
8 hedge funds and large institutions have $7.13M invested in Odonate Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 42 closing their positions.
78% less capital invested
Capital invested by funds: $32.7M → $7.13M (-$25.6M)
84% less funds holding
Funds holding: 50 → 8 (-42)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 42
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
-$17.2M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
-$1.81M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.3M |
| 4 |
BlackRock
New York
|
-$541K |
| 5 |
D.E. Shaw & Co
New York
|
-$505K |
ODT Hedge Fund Activity: Q1 2022 in Review
8 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Odonate Therapeutics, Inc. Common Stock (ODT) for Q1 2022, worth a combined $7.13M — down 78% from $32.7M a quarter earlier.
Sellers outnumbered buyers: 42 funds closed out of ODT and 0 opened new positions — a net loss of 42 holders — while 4 trimmed existing stakes and 0 added.
The largest seller was Tang Capital Management, exiting entirely with an estimated $17.2M sold.
- 8 institutional investors held Odonate Therapeutics, Inc. Common Stock (ODT) as of Q1 2022, down from 50 in Q4 2021.
- Funds reported $7.13M of Odonate Therapeutics, Inc. Common Stock stock for Q1 2022, down 78% quarter-over-quarter.
- 0 funds opened new Odonate Therapeutics, Inc. Common Stock positions in Q1 2022 and 42 closed out, a net change of -42 holders.
- The largest Odonate Therapeutics, Inc. Common Stock seller in Q1 2022 was Tang Capital Management, an estimated $17.2M sold.
Based on aggregated 13F filings for Q1 2022.